Trials / Completed
CompletedNCT00035841
Phase 2 Study of TLK286 in Metastatic Breast Cancer
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 60 (planned)
- Sponsor
- Telik · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the effectiveness of TLK286 in treatment of metastatic breast cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TLK286 |
Timeline
- Start date
- 2002-04-01
- Primary completion
- 2004-07-01
- Completion
- 2004-07-01
- First posted
- 2002-05-07
- Last updated
- 2011-07-25
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00035841. Inclusion in this directory is not an endorsement.